A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children
A Randomised Trial of the Efficacy and Safety of Four Drug Regimens When Used for Intermittent Preventive Treatment of Malaria in Senegalese Children
Sponsor: Cheikh Anta Diop University, Senegal
Listed as NCT00132548, this PHASE3 trial focuses on Malaria and remains completed. Sponsored by Cheikh Anta Diop University, Senegal, it has been updated 6 times since 2004, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jun 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cheikh Anta Diop University, Senegal
- Institut de Recherche pour le Developpement, Senegal
- London School of Hygiene and Tropical Medicine
- Ministry of Health, Senegal
For direct contact, visit the study record on ClinicalTrials.gov .